vs

Side-by-side financial comparison of Coursera, Inc. (COUR) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Coursera, Inc. is the larger business by last-quarter revenue ($196.9M vs $142.0M, roughly 1.4× Oncology Institute, Inc.). Oncology Institute, Inc. runs the higher net margin — -5.3% vs -13.6%, a 8.3% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 9.9%). Coursera, Inc. produced more free cash flow last quarter ($5.4M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 7.9%).

Coursera Inc. is an American for-profit online university, earlier operating as a global massive open online course provider from 2012 until 2021. It was founded in 2012 by Stanford University computer science professors Andrew Ng and Daphne Koller. Coursera works with universities and other organizations to offer online courses, certifications, and degrees in a variety of subjects.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

COUR vs TOI — Head-to-Head

Bigger by revenue
COUR
COUR
1.4× larger
COUR
$196.9M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+31.7% gap
TOI
41.6%
9.9%
COUR
Higher net margin
TOI
TOI
8.3% more per $
TOI
-5.3%
-13.6%
COUR
More free cash flow
COUR
COUR
$3.2M more FCF
COUR
$5.4M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
7.9%
COUR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COUR
COUR
TOI
TOI
Revenue
$196.9M
$142.0M
Net Profit
$-26.8M
$-7.5M
Gross Margin
54.2%
Operating Margin
-16.4%
-4.9%
Net Margin
-13.6%
-5.3%
Revenue YoY
9.9%
41.6%
Net Profit YoY
-24.1%
43.0%
EPS (diluted)
$-0.16
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COUR
COUR
TOI
TOI
Q4 25
$196.9M
$142.0M
Q3 25
$194.2M
$136.6M
Q2 25
$187.1M
$119.8M
Q1 25
$179.3M
$104.4M
Q4 24
$179.2M
$100.3M
Q3 24
$176.1M
$99.9M
Q2 24
$170.3M
$98.6M
Q1 24
$169.1M
$94.7M
Net Profit
COUR
COUR
TOI
TOI
Q4 25
$-26.8M
$-7.5M
Q3 25
$-8.6M
$-16.5M
Q2 25
$-7.8M
$-17.0M
Q1 25
$-7.8M
$-19.6M
Q4 24
$-21.6M
$-13.2M
Q3 24
$-13.7M
$-16.1M
Q2 24
$-22.9M
$-15.5M
Q1 24
$-21.3M
$-19.9M
Gross Margin
COUR
COUR
TOI
TOI
Q4 25
54.2%
Q3 25
54.6%
Q2 25
54.9%
Q1 25
54.6%
Q4 24
53.3%
Q3 24
54.6%
Q2 24
53.0%
Q1 24
52.9%
Operating Margin
COUR
COUR
TOI
TOI
Q4 25
-16.4%
-4.9%
Q3 25
-8.0%
-5.9%
Q2 25
-8.1%
-9.4%
Q1 25
-8.0%
-9.5%
Q4 24
-17.0%
-11.9%
Q3 24
-12.3%
-13.9%
Q2 24
-18.3%
-16.6%
Q1 24
-17.6%
-19.0%
Net Margin
COUR
COUR
TOI
TOI
Q4 25
-13.6%
-5.3%
Q3 25
-4.4%
-12.1%
Q2 25
-4.2%
-14.2%
Q1 25
-4.4%
-18.8%
Q4 24
-12.1%
-13.1%
Q3 24
-7.8%
-16.1%
Q2 24
-13.4%
-15.7%
Q1 24
-12.6%
-21.0%
EPS (diluted)
COUR
COUR
TOI
TOI
Q4 25
$-0.16
$-0.04
Q3 25
$-0.05
$-0.14
Q2 25
$-0.05
$-0.15
Q1 25
$-0.05
$-0.21
Q4 24
$-0.13
$-0.14
Q3 24
$-0.09
$-0.18
Q2 24
$-0.15
$-0.17
Q1 24
$-0.14
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COUR
COUR
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$792.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$635.7M
$-15.7M
Total Assets
$1.0B
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COUR
COUR
TOI
TOI
Q4 25
$792.6M
Q3 25
$797.7M
Q2 25
$775.1M
Q1 25
$748.0M
Q4 24
$726.1M
Q3 24
$719.4M
Q2 24
$708.8M
$9.9M
Q1 24
$725.4M
$29.8M
Stockholders' Equity
COUR
COUR
TOI
TOI
Q4 25
$635.7M
$-15.7M
Q3 25
$639.5M
$-12.3M
Q2 25
$627.0M
$-9.0M
Q1 25
$610.5M
$5.1M
Q4 24
$597.4M
$3.6M
Q3 24
$593.3M
$15.5M
Q2 24
$585.2M
$29.2M
Q1 24
$609.1M
$41.3M
Total Assets
COUR
COUR
TOI
TOI
Q4 25
$1.0B
$164.7M
Q3 25
$995.3M
$163.6M
Q2 25
$979.9M
$159.8M
Q1 25
$951.2M
$164.0M
Q4 24
$930.3M
$172.7M
Q3 24
$914.1M
$179.2M
Q2 24
$904.4M
$179.6M
Q1 24
$916.3M
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COUR
COUR
TOI
TOI
Operating Cash FlowLast quarter
$5.8M
$3.2M
Free Cash FlowOCF − Capex
$5.4M
$2.2M
FCF MarginFCF / Revenue
2.7%
1.5%
Capex IntensityCapex / Revenue
0.2%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$107.2M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COUR
COUR
TOI
TOI
Q4 25
$5.8M
$3.2M
Q3 25
$33.9M
$-12.6M
Q2 25
$35.5M
$-10.2M
Q1 25
$33.5M
$-5.0M
Q4 24
$19.2M
$4.2M
Q3 24
$27.9M
$819.0K
Q2 24
$23.8M
$-15.7M
Q1 24
$24.5M
$-15.9M
Free Cash Flow
COUR
COUR
TOI
TOI
Q4 25
$5.4M
$2.2M
Q3 25
$33.7M
$-13.2M
Q2 25
$35.1M
$-11.4M
Q1 25
$33.0M
$-5.3M
Q4 24
$18.1M
$2.4M
Q3 24
$27.7M
$417.0K
Q2 24
$23.6M
$-17.5M
Q1 24
$24.4M
$-16.5M
FCF Margin
COUR
COUR
TOI
TOI
Q4 25
2.7%
1.5%
Q3 25
17.4%
-9.7%
Q2 25
18.8%
-9.5%
Q1 25
18.4%
-5.1%
Q4 24
10.1%
2.4%
Q3 24
15.7%
0.4%
Q2 24
13.9%
-17.7%
Q1 24
14.4%
-17.4%
Capex Intensity
COUR
COUR
TOI
TOI
Q4 25
0.2%
0.7%
Q3 25
0.1%
0.4%
Q2 25
0.2%
1.0%
Q1 25
0.3%
0.3%
Q4 24
0.6%
1.8%
Q3 24
0.1%
0.4%
Q2 24
0.1%
1.9%
Q1 24
0.1%
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COUR
COUR

Consumer Segment$131.5M67%
Enterprise Segment$65.4M33%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons